These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1195 related items for PubMed ID: 19558268

  • 1. Continuous positive airway pressure therapy improves hypoadiponectinemia in severe obese men with obstructive sleep apnea without changes in insulin resistance.
    Carneiro G, Togeiro SM, Ribeiro-Filho FF, Truksinas E, Ribeiro AB, Zanella MT, Tufik S.
    Metab Syndr Relat Disord; 2009 Dec; 7(6):537-42. PubMed ID: 19558268
    [Abstract] [Full Text] [Related]

  • 2. Effects of nasal continuous positive airway pressure treatment on oxidative stress and adiponectin levels in obese patients with obstructive sleep apnea.
    de Lima AM, Franco CM, de Castro CM, Bezerra Ade A, Ataíde L, Halpern A.
    Respiration; 2010 Dec; 79(5):370-6. PubMed ID: 19590157
    [Abstract] [Full Text] [Related]

  • 3. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance.
    Makino S, Handa H, Suzukawa K, Fujiwara M, Nakamura M, Muraoka S, Takasago I, Tanaka Y, Hashimoto K, Sugimoto T.
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):12-9. PubMed ID: 16402923
    [Abstract] [Full Text] [Related]

  • 4. Resistin is closely related to systemic inflammation in obstructive sleep apnea.
    Yamamoto Y, Fujiuchi S, Hiramatsu M, Nishigaki Y, Takeda A, Fujita Y, Yamazaki Y.
    Respiration; 2008 Jan; 76(4):377-85. PubMed ID: 18577878
    [Abstract] [Full Text] [Related]

  • 5. Comparison of serum adiponectin and tumor necrosis factor-alpha levels between patients with and without obstructive sleep apnea syndrome.
    Kanbay A, Kokturk O, Ciftci TU, Tavil Y, Bukan N.
    Respiration; 2008 Jan; 76(3):324-30. PubMed ID: 18487876
    [Abstract] [Full Text] [Related]

  • 6. Effect of continuous positive airway pressure therapy on hypothalamic-pituitary-adrenal axis function and 24-h blood pressure profile in obese men with obstructive sleep apnea syndrome.
    Carneiro G, Togeiro SM, Hayashi LF, Ribeiro-Filho FF, Ribeiro AB, Tufik S, Zanella MT.
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E380-4. PubMed ID: 18523125
    [Abstract] [Full Text] [Related]

  • 7. Sleep apnea is a manifestation of the metabolic syndrome.
    Vgontzas AN, Bixler EO, Chrousos GP.
    Sleep Med Rev; 2005 Jun; 9(3):211-24. PubMed ID: 15893251
    [Abstract] [Full Text] [Related]

  • 8. Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome.
    Christou K, Kostikas K, Pastaka C, Tanou K, Antoniadou I, Gourgoulianis KI.
    Sleep Med; 2009 Jan; 10(1):87-94. PubMed ID: 18077211
    [Abstract] [Full Text] [Related]

  • 9. [Association between residual sleepiness and central sleep apnea events in patients with obstructive sleep apnea syndrome].
    Yao SM, Zhang XL.
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Sep; 31(9):664-9. PubMed ID: 19080566
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular risk and insulin resistance in patients with obstructive sleep apnea.
    Tkacova R, Dorkova Z, Molcanyiova A, Radikova Z, Klimes I, Tkac I.
    Med Sci Monit; 2008 Sep; 14(9):CR438-44. PubMed ID: 18758413
    [Abstract] [Full Text] [Related]

  • 11. [Long term effect of autoadjusting positive airway pressure on C-reactive protein and interleukin-6 in men with obstructive sleep apnoea syndrome].
    Drummond M, Winck J, Guimarães J, Santos AC, Almeida J, Marques J.
    Arch Bronconeumol; 2009 Dec; 45(12):577-84. PubMed ID: 19552994
    [Abstract] [Full Text] [Related]

  • 12. Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial.
    Kohler M, Ayers L, Pepperell JC, Packwood KL, Ferry B, Crosthwaite N, Craig S, Siccoli MM, Davies RJ, Stradling JR.
    Thorax; 2009 Jan; 64(1):67-73. PubMed ID: 18786982
    [Abstract] [Full Text] [Related]

  • 13. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients.
    Kopp HP, Kopp CW, Festa A, Krzyzanowska K, Kriwanek S, Minar E, Roka R, Schernthaner G.
    Arterioscler Thromb Vasc Biol; 2003 Jun 01; 23(6):1042-7. PubMed ID: 12714437
    [Abstract] [Full Text] [Related]

  • 14. Impact of nasal continuous positive airway pressure therapy on markers of platelet activation in patients with obstructive sleep apnea.
    Akinnusi ME, Paasch LL, Szarpa KR, Wallace PK, El Solh AA.
    Respiration; 2009 Jun 01; 77(1):25-31. PubMed ID: 18812691
    [Abstract] [Full Text] [Related]

  • 15. Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-CRP levels in patients with sleep-disordered breathing in Delhi.
    Sharma SK, Mishra HK, Sharma H, Goel A, Sreenivas V, Gulati V, Tahir M.
    Sleep Med; 2008 Jan 01; 9(2):149-56. PubMed ID: 17638590
    [Abstract] [Full Text] [Related]

  • 16. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome.
    Ciftci TU, Kokturk O, Bukan N, Bilgihan A.
    Cytokine; 2004 Oct 21; 28(2):87-91. PubMed ID: 15381186
    [Abstract] [Full Text] [Related]

  • 17. Falls in blood pressure in patients with obstructive sleep apnoea after long-term nasal continuous positive airway pressure treatment.
    Chin K, Nakamura T, Takahashi K, Sumi K, Matsumoto H, Niimi A, Fukuhara S, Mishima M, Nakamura T.
    J Hypertens; 2006 Oct 21; 24(10):2091-9. PubMed ID: 16957571
    [Abstract] [Full Text] [Related]

  • 18. Sleep apnea is associated with bronchial inflammation and continuous positive airway pressure-induced airway hyperresponsiveness.
    Devouassoux G, Lévy P, Rossini E, Pin I, Fior-Gozlan M, Henry M, Seigneurin D, Pépin JL.
    J Allergy Clin Immunol; 2007 Mar 21; 119(3):597-603. PubMed ID: 17261329
    [Abstract] [Full Text] [Related]

  • 19. Plasma apelin levels in obstructive sleep apnea and the effect of continuous positive airway pressure therapy.
    Henley DE, Buchanan F, Gibson R, Douthwaite JA, Wood SA, Woltersdorf WW, Catterall JR, Lightman SL.
    J Endocrinol; 2009 Oct 21; 203(1):181-8. PubMed ID: 19643928
    [Abstract] [Full Text] [Related]

  • 20. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea.
    Dyugovskaya L, Lavie P, Lavie L.
    Ann N Y Acad Sci; 2005 Jun 21; 1051():340-50. PubMed ID: 16126976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.